Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.02.2013 | editorial

Treatment results for children and adolescents with acute myeloid leukemia in Middle and Eastern European countries

verfasst von: Prof. Dr. med. Ursula Creutzig, PD Dr. med. Gesche Tallen, MD, PhD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Excerpt

Acute myeloid leukemia (AML) corresponds to a heterogeneous group of hematologic neoplasms that originate from bone marrow precursors of the myeloid, monocyte, erythroid, and megakaryocytic cell lineages. While acute lymphoblastic leukemia (ALL) remains the most common childhood malignancy, AML comprises only about 4.8 % of all pediatric cancers in Europe. However, although an orphan disease and despite of remarkable advances during the past decades in both the management and the understanding of the biology and molecular genetics of childhood AML, it still remains one of the most frequent causes of death in children and adolescents with cancer. …
Vorheriger Artikel Future of stereotactic intervention in lung cancer
Nächster Artikel Thymic malignancies focusing on systemic treatment
Literatur
1.
Creutzig U, Van Den Heuvel-Eibrink MM, Gibson B, et al. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood. 2012;120:3187–205.PubMedCrossRef
2.
Stary J. Long-term results of national treatment trials in childhood acute lymphoblastic leukaemia in several Middle/East European countries. Memo. 2011;4:140–1.CrossRef
3.
Dluzniewska A, Balwierz W, Armata J, et al. Twenty years of Polish experience with three consecutive protocols for treatment of childhood acute myelogenous leukemia. Leukemia. 2005;19:2117–24.PubMedCrossRef
4.
Reinhardt D, von Neuhoff C, Sander A, et al. Genetic prognostic factors in childhood acute myeloid leukemia. Klin Padiatr. 2012;224:372–6.PubMedCrossRef
5.
Creutzig U, Ritter J, Budde M, et al. Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia: Associations with hyperleukocytosis and acute monocytic leukemia. Cancer. 1987;60:3071–9.PubMedCrossRef
6.
Creutzig U, Zimmermann M, Reinhardt D, et al. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol. 2004;22:4384–93.PubMedCrossRef
7.
Creutzig U, Ritter J, Schellong G. Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in the study AML-BFM-83 as compared with study AML-BFM-78. Blood. 1990;75:1932–40.PubMed
8.
Creutzig U, Zimmermann M, Ritter J, et al. Definition of a standard-risk group in children with AML. Brit J Haematol. 1999;104:630–9.CrossRef
9.
Creutzig U, Zimmermann M, Lehrnbecher T, et al. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. J Clin Oncol. 2006;24:4499–506.PubMedCrossRef
10.
Kaspers GJL, Zimmerman M, Reinhardt D, et al. Improved outcome in pediatric relapsed AML: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group. J Clin Oncol. 2013 (Epub ahead of print).
11.
Steliarova-Foucher E, Stiller C, Kaatsch P, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study. Lancet. 2004;364:2097–105.PubMedCrossRef
12.
Tallen G, Henze G, Creutzig U, Dworzak M, Klingebiel T. Auswirkungen der EU-Direktive für klinische Studien auf Kinder und Jugendliche mit Krebserkrankungen in Europa. FORUM-DKG. 2010;25:42–8.
13.
Kowalczyk J. Current clinical trials: challenges in Central and Eastern Europe. SIOPe News 2008.
14.
Balwierz W, Pawinska-Wasikowska K, Klekawka T, et al. Development of treatment and clinical results in childhood acute myeloid leukemia in Poland. Memo. 2013;1. doi:10.1007/s12254-012-0061-9.
15.
Sramkova L, Sterba J, Hrstkova H, et al. Development of treatment and clinical results in childhood acute myeloid leukemia in the Czech Republic. Memo. 2013;1. doi:10.1007/s12254-012-0059-3.
16.
Szegedi I, Jakab Z, Masath P, et al. Development of treatment and clinical results in childhood acute myeloid leukemia in Hungary. Memo. 2013;1. doi:10.1007/s12254-012-0054-8.
17.
Kolenova A, Bubanska E, Oravkinova I, et al. Development of treatment and clinical results in childhood acute myeloid leukemia in the Slovak Republic. Memo. 2013;1. doi:10.1007/s12254-012-0052-x.
18.
Krstovski N, Kuzmanovic M, Vujic D, et al. Treatment results of childhood acute myeloid leukemia in Serbia. Memo. 2013;1. doi:10.1007/s12254-012-0051-y.
Metadaten
Titel
Treatment results for children and adolescents with acute myeloid leukemia in Middle and Eastern European countries
verfasst von
Prof. Dr. med. Ursula Creutzig
PD Dr. med. Gesche Tallen, MD, PhD
Publikationsdatum
01.02.2013
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 1/2013
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-013-0070-3

Weitere Artikel der Ausgabe 1/2013

The role of maintenance strategies in upper gastrointestinal (GI) and pancreatic carcinoma

  • short review

Development of treatment and clinical results in childhood acute myeloid leukemia in Poland

  • Open Access
  • review

Management of immunosuppression in the treatment of chronic lymphocytic leukemia

  • short review

Maintenance therapy in NSCLC

  • short review

Future of stereotactic intervention in lung cancer

  • editorial

Thymic malignancies focusing on systemic treatment

  • review